Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B.
Treatment of bacterial lipopolysaccharides (endotoxins) isolated from Salmonella minnesota R595 or purified lipid A with the antibiotic polymyxin B has been demonstrated to abrogate the ability of these molecules to activate serum complement. The inhibition is a function of the ratio of polymyxin B...
Sparad:
| I publikationen: | Infect Immun |
|---|---|
| Huvudupphov: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1976
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC420610/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/175019/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.13.1.298-301.1976 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|